NCT00677859View on ClinicalTrials.gov

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

November 30, 2011

Conditions
Hematologic Malignancies
Interventions
BIOLOGICAL

MultiStem®

Patients will receive a single IV infusion of MultiStem® 2 days after HSCT.

BIOLOGICAL

MultiStem®

Patients will receive either 3 weekly IV infusions or 5 weekly infusions of MultiStem®

Trial Locations (6)

19104

University of Pennsylvania, Philadelphia

44106

University Hospitals Case Medical Center, Cleveland

78229

Texas Transplant Institute, San Antonio

85054

Mayo Clinic Hospital, Phoenix

97239

Oregon State University Medical Center, Portland

Unknown

UZ Leuven, Leuven

Sponsors

Lead Sponsor

Healios K.K.

Collaborators (1)

Cato Research
All Listed Sponsors
collaborator

Cato Research

INDUSTRY

lead

Healios K.K.

INDUSTRY